GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » EV-to-Revenue

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) EV-to-Revenue : 3.21 (As of Jun. 07, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hunan Jingfeng Pharmaceutical Co's enterprise value is ¥1,865.2 Mil. Hunan Jingfeng Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥581.4 Mil. Therefore, Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue for today is 3.21.

The historical rank and industry rank for Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SZSE:000908' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.88   Med: 3.95   Max: 19.85
Current: 3.21

During the past 13 years, the highest EV-to-Revenue of Hunan Jingfeng Pharmaceutical Co was 19.85. The lowest was 1.88. And the median was 3.95.

SZSE:000908's EV-to-Revenue is ranked worse than
63.92% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.255 vs SZSE:000908: 3.21

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-07), Hunan Jingfeng Pharmaceutical Co's stock price is ¥1.39. Hunan Jingfeng Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.65. Therefore, Hunan Jingfeng Pharmaceutical Co's PS Ratio for today is 2.13.


Hunan Jingfeng Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co EV-to-Revenue Chart

Hunan Jingfeng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.70 6.21 5.62 3.87 5.06

Hunan Jingfeng Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.72 3.31 3.99 5.06 4.65

Competitive Comparison of Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue falls into.



Hunan Jingfeng Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1865.186/581.414
=3.21

Hunan Jingfeng Pharmaceutical Co's current Enterprise Value is ¥1,865.2 Mil.
Hunan Jingfeng Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥581.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Jingfeng Pharmaceutical Co  (SZSE:000908) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hunan Jingfeng Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.39/0.654
=2.13

Hunan Jingfeng Pharmaceutical Co's share price for today is ¥1.39.
Hunan Jingfeng Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.65.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Jingfeng Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Traded in Other Exchanges
N/A
Address
500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN
Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.
Executives
Zhou Shen Dong Supervisors
Ye Xiang Wu Directors, executives
Ma Xian Peng Executives
Cong Shu Fen Executives
Zhang Jun Guo Executives
Jian Wei Guang Directors, executives
Bi Yuan Secretary, Director
Ou Yang Yan Li Secretary, Director
Luo Li Director
Luo Bin Director
Li Tong Directors, executives
Wei Ze Chun Director
Tang Zhi Executives
Ou Yang Chun Bao Executives
Mao Hui Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines